AFP and hepatocellular carcinoma: Toso et al. [53] evaluated a large cohort of 6000 European LT patients and demonstrated that the subgroup of recipients who presented a total tumor volume (TTV) of ≤115 cm3 and AFP serum levels ≤ 400 ng/mL experienced a lower risk of HCC recurrence and better survival after LT.